| Turcja | Austria | Hiszpania | |
| Terapia egzosomami dla odmłodzenia pochwy | od $1,800 | - | - |
Państwo nie płacą za usługi Bookimed. Ceny na terapię egzosomami dla odmłodzenia pochwy na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu terapii egzosomami dla odmłodzenia pochwy. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Terapia egzosomami dla odmłodzenia pochwy.
Specjalizuje się w rewitalizacji pochwy za pomocą zaawansowanych technik, takich jak laser CO2 Mona Lisa Touch i terapia egzosomowa. Szkolenie odbył/odbyła w prestiżowych instytucjach, w tym London Harris Birthright.
Dr. Ahmet KIRKINCI is a specialist physician (operator doctor) in obstetrics and gynecology. He provides prenatal care and delivery. He performs laparoscopic surgery, hysteroscopy and hysterectomy, and incontinence surgery. He also manages IUI, PCOS, and menopausal hormone therapy. He offers colposcopy and HPV care.
He graduated from Erzurum Atatürk University in 2015. He worked at Erzurum No. 12 Family Health Center from 2015 to 2019. He served at Erzincan Binali Yıldırım University from 2019 to 2023. He then joined Bayburt State Hospital from 2023 to 2025. He moved to Optimed International Çorlu Hospital in 2025. He is proficient in English.
He has co‑authored studies on hysterectomy outcomes. He has also researched first‑trimester SARS‑CoV‑2 and miscarriage, biomarkers in oligohydramnios, and prediction of ectopic pregnancy treatment. His work includes the effects of single OGTT values and host genetics in pregnant patients with COVID‑19. These papers appeared in the Taiwan Journal of Obstetrics and Gynecology, Anais da Academia Brasileira de Ciências, and the Journal of Clinical Obstetrics and Gynecology. He has also posted preprints on SSRN and ResearchGate.
Dr. Do‑young Jeong is an obstetrician‑gynecologist focused on minimally invasive, single‑port, and robotic surgery. Dr. Jeong completed an internship at Seoul National University Hospital. Dr. Jeong completed residency and graduate training at Korea University. Dr. Jeong then completed a fellowship in gynecologic oncology at the National Cancer Center, focusing on uterine and ovarian disease. Dr. Jeong served as director and chief medical officer at MizMedi Hospital and Incheon Sejong Hospital. Dr. Jeong later served as vice president at Dongtan Jeil Hospital. Dr. Jeong is a Clinical Professor at Kyung Hee University Hospital at Gangdong and an Adjunct Professor at Korea University. Dr. Jeong also serves on expert committees for KSGO, MOHW, MFDS, and KHIDI.
Professional memberships include the Korean societies for obstetrics and gynecology, gynecologic endoscopy, gynecologic robotic surgery, and reproductive medicine, as well as ISUOG. Dr. Jeong holds patents for single‑port surgical devices, including a camera, access ring, and irrigation system. Honors include the Korea University Outstanding Resident Award and the KSGE Best Poster Award. Dr. Jeong was first author of SCI‑indexed papers in 2013 and 2014. From 2023 to 2025, Dr. Jeong led studies on da Vinci SP myomectomy and hysterectomy, and on HIFU.